Cambrian BioPharma Inc is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health.

As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Cambrian’s approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve the overall quality of life as we age. To date, Cambrian has well over a dozen novel therapeutics in development across its pipeline. For more information, please visit www.cambrianbio.com or follow us on Twitter @CambrianBio and LinkedIn.